Ads
related to: what is multiple myeloma- About Multiple Myeloma
Learn More About Treatments At
First Relapse For Your Patients.
- Efficacy Information
Review Clinical Data, Results,
Study Overviews, And More.
- Access & Reimbursement
Find Support, Tools, And Resources
For HCPs, Caregivers And Patients.
- HCP FAQs
Discover Answers To Commonly Asked
Questions At The Official HCP Site.
- Safety Information
View Safety Profiles For
A Combination Treatment.
- Connect With A Rep
Contact A Field Representative For
Questions Or To Schedule A Visit.
- About Multiple Myeloma
Search results
Amrita Krishnan
Los Angeles Times· 7 hours agoDr. Amrita Krishnan, M.D., Executive Medical Director of Hematology, is a leading figure in cancer research and treatment, particularly in multiple myeloma, at City of Hope Orange County.
Europe approves new multiple myeloma therapy CARVYKTI By Investing.com
Investing.com· 6 days agoThe European Commission has granted approval to CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for...
Study points to racial and social barriers that block treatment for multiple myeloma
Medical Xpress· 5 days agoAn analysis of data from three California health care organizations, published in Clinical Lymphoma,...
Biomarkers identified for successful treatment of bone marrow tumors
Medical Xpress· 2 days agoCAR T cell therapy has proven effective in treating various hematological cancers. In a clinical study, researchers from the University of Leipzig Medical Center and the Fraunhofer Institute ...
'10-foot tall and bulletproof': North Collier firefighter educates others on cancer safety
Naples Daily News via Yahoo News· 7 hours agoAfter they exit the billowing smoke and burning flames, they place their clothing into the bucket...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 2 days agoThe European Commission (“EC”) approved J&J’s JNJ Carvykti for earlier lines of treatment in...
Should You Be Bullish on Arcellx (ACLX)?
Insider Monkey via Yahoo Finance· 5 days agoBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 3 days agoIts third highest-grossing product, the multiple myeloma treatment Revlimid, already faces limited...
Bristol Myers taps startup to boost cell therapy production
BioPharma Dive via Yahoo Finance· 6 days agoBristol Myers currently sells two so-called CAR-T cell therapies, Breyanzi for lymphoma and Abecma...
Commerzbank Aktiengesellschaft FI Buys New Shares in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 5 days agoCommerzbank Aktiengesellschaft FI bought a new stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) during the 4th quarter, according to the company in its most recent disclosure ...
Ads
related to: what is multiple myeloma
